[EN] ALLOSTERIC BINDING COMPOUNDS<br/>[FR] COMPOSÉS DE LIAISON ALLOSTÉRIQUES
申请人:UNIV AARHUS
公开号:WO2010094289A1
公开(公告)日:2010-08-26
The present invention relates to allosteric binding compounds of formula (I), especially for the treatment of CNS disorders, together with pharmaceutical compositions and methods of treatment including these compounds.
[EN] PROCESS FOR DEOXYFLUORINATION OF PHENOLS<br/>[FR] PROCÉDÉ DE DÉSOXYFLUORATION DE PHÉNOLS
申请人:STUDIENGESELLSCHAFT KOHLE MBH
公开号:WO2019025137A1
公开(公告)日:2019-02-07
The present invention refers to a process for transition-meta!-assisted 18F- deoxyfluorination of phenols. The transformation benefits from readily available phenols as starting materials; tolerance of moisture and ambient atmosphere, large substrate scope, and translatability to generate doses appropriate for positron emission tomography (PET) imaging.
The present invention relates to allosteric binding compounds of formula (I), especially for the treatment of CNS disorders, together with pharmaceutical compositions and methods of treatment including these compounds.
The present invention refers to a process for transition-metal-assisted 18F-deoxyfluorination of phenols. The transformation benefits from readily available phenols as starting materials, tolerance of moisture and ambient atmosphere, large substrate scope, and translatability to generate doses appropriate for positron emission tomography (PET) imaging.
The present invention refers to a process for transition-metal-assisted 18F-deoxyfluorination of phenols. The transformation benefits from readily available phenols as starting materials, tolerance of moisture and ambient atmosphere, large substrate scope, and translatability to generate doses appropriate for positron emission tomography (PET) imaging.